| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash | 23,785,771 | |||
| Accounts receivable | 9,244,321 | |||
| Product deposit | 370,518 | |||
| Inventory | 3,432,382 | |||
| Other current assets | 4,252,613 | |||
| Total current assets | 41,085,605 | |||
| Equipment, net | 2,584,829 | |||
| Right of use assets, net | 5,578,992 | |||
| Capitalized computer software, net | 15,175,634 | |||
| Intangible assets, net | 1,558,318 | |||
| Total non-current assets | 24,897,773 | |||
| Total assets | 65,983,378 | |||
| Accounts payable | 19,554,735 | |||
| Accrued expenses | 22,079,805 | |||
| Current operating lease liabilities | 673,482 | |||
| Deferred revenue | 14,355,531 | |||
| Total current liabilities | 56,663,553 | |||
| Noncurrent operating lease liabilities | 5,851,673 | |||
| Contingent consideration | 100,000 | |||
| Total liabilities | 62,615,226 | |||
| Series a preferred stock, 0.0001 par value 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, 35.8 million as of september 30, 2025 and december 31, 2024 | 140 | |||
| Common stock, 0.01 par value 100,000,000 shares authorized, 46,686,350 and 42,293,907 shares issued, 46,583,310 and 42,190,867 outstanding as of september 30, 2025 and december 31, 2024, respectively | 466,864 | |||
| Additional paid-in capital | 248,801,209 | |||
| Accumulated deficit | -247,790,178 | |||
| Treasury stock, 103,040, at cost, as of september 30, 2025 and december 31, 2024 | 163,701 | |||
| Total lifemd, inc. stockholders equity (deficit) | 1,314,334 | |||
| Non-controlling interest | 2,053,818 | |||
| Total stockholders equity (deficit) | 3,368,152 | |||
| Total liabilities and stockholders equity (deficit) | 65,983,378 | |||
LifeMD, Inc. (LFMDP)
LifeMD, Inc. (LFMDP)